Sage Journals: Discover world-class research

Free access

Research article

First published 2009-07

Development and Evaluation of a FACS-Based Medium-Throughput Assay for HCV Entry Inhibitors

Sigrid Ziegler, Bernd Kronenberger, Beatrice A.-M. Albrecht [...]

Journal of Biomolecular Screening

Free access

Research article

First published 2019-7

Discovery and Characterization of a Novel HCV Inhibitor Targeting the Late Stage of HCV Life Cycle

Seung Bum Park, Audrey Boyer, Zongyi Hu [...]

Antiviral Therapy

Free access

Review article

First published 2011-11

Impact of HCV Protease-Inhibitor-Based Triple Therapy for Chronic HCV Genotype 1 Infection

Peter Ferenci, K Rajender Reddy

Antiviral Therapy

Free access

Case report

First published 2013-5

A Boceprevir Failure in a Patient Infected with HCV Genotype 1G: Importance and Limitations of Virus Genotyping Prior to HCV Protease-Inhibitor-Based Therapy

Valeria Cento, Simona Landonio, Francesca De Luca [...]

Antiviral Therapy

Free access

Research article

First published 2010-7

Safety and Antiviral Activity of JTK-652: A Novel HCV Infection Inhibitor

Joep de Bruijne, Jilling F Bergmann, Christine J Weegink [...]

Antiviral Therapy

Free access

Announcement

First published 2012-7

Prevalence of Natural Polymorphisms at the HCV Ns5A Gene Associated with Resistance to Daclatasvir,An Ns5A Inhibitor

Zulema Plaza, Vincent Soriano, Eugenia Vispo [...]

Antiviral Therapy

Free access

Research article

First published 2011-7

Impact of Ribavirin on HCV Replicon RNA Decline during Treatment with Interferon-α and the Protease Inhibitors Boceprevir or Telaprevir

Wolf Peter Hofmann, Tje Lin Chung, Carola Osbahr [...]

Antiviral Therapy

Free access

Research article

First published 2011-10

NS3 Protease Polymorphism and Natural Resistance to Protease Inhibitors in French Patients Infected with HCV Genotypes 1–5

the ANRS AC11 HCV Group, Sophie Vallet, Florent Viron [...]

Antiviral Therapy

Free access

Research article

First published 2002-04

A Collaborative Screening Program for the Discovery of Inhibitors of HCV NS2/3 cis-Cleaving Protease Activity

Mike Whitney, Jeffrey H. Stack, Paul L. Darke [...]

Journal of Biomolecular Screening

Free access

Research article

First published 2017-7

Preclinical Characterization of the Novel HCV NS3 Protease Inhibitor GS-9256

Huiling Yang, Chris Yang, Yujin Wang [...]

Antiviral Therapy

Search results